Measles virus (MV) infects dendritic cells (DCs) resulting in immunosuppression. Human DCs express two MV receptors: CD46 and human signaling lymphocyte activation molecule (hSLAM); thus, the role played by either alone is unclear. Because wild-type (wt) MV uses hSLAM receptor preferentially, we dissected the molecular basis of MV -DC interaction and resultant immunosuppression through the hSLAM receptor by creating transgenic (tg) mice expressing hSLAM on DCs. After infection with wt MV, murine splenic DCs expressing hSLAM receptor had less B7-1, B7-2, CD40, MHC class I, and MHC class II molecules on their surfaces and displayed an increased rate of apoptosis when compared to uninfected DCs. Further, MV-infected DCs failed to stimulate allogeneic T cells and inhibited mitogendependent T-cell proliferation. Individual expression of human SLAM, interferon a/h receptor, tumor necrosis factor-a, and lymphotoxin-a or h from T cells was not required for MV-infected DCs to inhibit the proliferation of T cells.
Introduction
Measles virus (MV) is a contagious human pathogen that continues to infect 30 -40 million humans annually leading to approximately 1 million deaths despite the availability of an effective attenuated vaccine (The World Health Report, 2002) . MV infects cells of the immune system and induces a transient but profound suppression of immune responses, which is the major cause of related fatalities (Griffin, 1995; McChesney and Oldstone, 1989) . How MV impairs immunity has been extensively studied and likely involves multiple mechanisms. T lymphocytes are permissive to MV infection (Hyypia et al., 1985; Joseph et al., 1975; Sullivan et al., 1975) leading subsequently to an inhibition of their proliferative responses to mitogens, alloantigens, and recalled antigens (McChesney et al., 1988; Naniche et al., 1999; Sun et al., 1998) . When MV infects antigen-presenting cells (APC) such as dendritic cells (DCs), the outcome is believed to be modulation of cross-talk between T cells and APC, thereby aborting the induction of adaptive immune responses (Schneider-Schaulies et al., 2003; Servet-Delprat et al., 2003) . Human DCs obtained from cultures of blood CD34 + cells, monocytes, and Langerhans cells are susceptible to MV infection in vitro (Dubois et al., 2001; Fugier-Vivier et al., 1997; Grosjean et al., 1997; Schnorr et al., 1997; Servet-Delprat et al., 2000a , 2000b . Such infection enhances apoptosis of DCs and inhibits CD40 ligand-dependent terminal differentiation of DCs. Additionally, cocultivation of MV-infected DCs with T cells increases Fas-mediated DC apoptosis as well as virus production. MV-infected DCs also upregulate their expression of TRAIL (Vidalain et al., 2000) and inhibit proliferation of naive and activated T cells.
Human DCs express the two known receptors for MV: CD46 and human signaling lymphocyte activation molecule (hSLAM) (Dorig et al., 1993; Erlenhoefer et al., 2001; Hsu et al., 2001; Manchester et al., 1994; Naniche et al., 1993; Tatsuo et al., 2000) . Human complement regulatory protein (CD46) is constitutively expressed on all nucleated cells (McQuaid and Cosby, 2002) , and transgenic (tg) mice expressing the human CD46 receptor have been generated and widely used to investigate the interaction of MV with neurons and cells of the immune system (Horvat et al., 1996; Lawrence et al., 1999; Oldstone et al., 1999; Patterson et al., 2002; Rall et al., 1997; Slifka et al., 2003; Yannoutsos et al., 1996) . However, wild-type (wt) MV or MV passaged on B95-8 cells does not use the CD46 receptor for entry into cells as efficiently as MV vaccine strains do. That is, the interaction of wt MV with CD46 is weaker than its interaction with hSLAM (Erlenhofer et al., 2002; Manchester et al., 2000; Ono et al., 2001a; Schneider et al., 2002) . SLAM is a prototypic receptor belonging to a SLAM subfamily within the CD2 immunoglobulin superfamily and facilitates modulation of lymphocyte proliferation and cytokine production (Cocks et al., 1995; Veillette and Latour, 2003) . SLAM family receptors mediate intracellular protein tyrosine phosphorylation signals dependent on the binding affinity to SLAM-associated protein (SAP) or EAT-2 (Chan et al., 2003; Engel et al., 2003) . The expression of SLAM is restricted to immune-system cells such as immature thymocytes, memory T cells, activated T cells, B cells, monocytes, and DCs (Cocks et al., 1995; McQuaid and Cosby, 2002; Minagawa et al., 2001; Murabayashi et al., 2002; Punnonen et al., 1997; Sidorenko and Clark, 1993) . MV binds to the V domain of hSLAM but does not bind to the mouse counterpart indicating that murine SLAM does not serve as a cellular receptor for MV (Ohno et al., 2003; Ono et al., 2001b) .
Despite numerous studies performed in vitro, the mechanism of immunosuppression caused by MV infection of human DCs remains obscure primarily because DCs simultaneously express the two MV receptors CD46 and SLAM, whose activities are, so far, inseparable. To address this issue and focus directly on MV interaction with SLAM on DCs, we created tg mice whose DCs expressed hSLAM by using the CD11c promoter. We report here that CD11c + DCs from tg mice expressed hSLAM protein and were permissive to MV, whereas DCs from non-tg mice had neither property. With this model, we showed that DCs infected with MV via hSLAM were deficient in stimulating allogeneic T cells in a mixed lymphocyte reaction (MLR) and causing naive T cells to proliferate in the presence of mitogens. These events were associated with MV-induced downregulation of MHC class I and II and B7-1, B7-2, and CD40 co-activation molecules on DCs, as well as enhanced apoptosis of DCs.
Results

Generation of tg mice expressing hSLAM on DCs
To express hSLAM on murine DCs, we created tg mice with hSLAM transcriptionally regulated by the CD11c promoter ( Fig. 1A) . Single cell suspensions from spleens of CD11c-hSLAM tg and non-tg mice were analyzed by flow cytometry for hSLAM protein expression on diverse immune cells. As shown in Fig. 1B , hSLAM protein was expressed on the surface of splenic CD11c + DCs, but not on T cells (CD4 + and CD8 + ), B cells (B220 + ), or NK cells (NK1.1 + ). A minimal level of hSLAM expression was detected on CD11c À CD11b + macrophages. Because bone marrow BM cells contain DC progenitors and have been widely used to generate CD11c + DCs in the presence of the cytokine GM-CSF, we generated BM-derived CD11c + DCs from hSLAM tg mice and investigated for their expression of hSLAM protein. Over time, as shown in Fig. 1C , BM cells in response to GM-CSF yielded equivalent numbers of CD11c + DCs in hSLAM tg as compared to non-tg mice. However, in BM-derived CD11c + DCs from tg mice, amounts of hSLAM protein increased over time (both CD11c + and hSLAM + cells: d3: 23%, d6: 34%, d9: 52%) whereas CD11c + cells from non-tg mice did not (Fig. 1C) . These data indicate that hSLAM protein was expressed on the surfaces of CD11c + DCs obtained from splenocytes and precursor BM stem cells.
MV infects and alters DCs from CD11c-hSLAM tg mice
To determine whether hSLAM expression on mouse CD11c + DCs rendered them susceptible to MV infection, DCs were enriched from splenocytes of tg or non-tg mice and then infected in vitro with wt JW strain of MV at 0.3 MOI. At 2 dpi, the expression of viral proteins on CD11c + DCs was assessed by flow cytometry (Hahm et al., 2003) . About 35% of CD11c + DCs from CD11c-hSLAM tg mice were infected with MV and expressed viral proteins on their surfaces. In contrast, fewer than 6% of CD11c + DCs from non-tg mice scored positive for MV proteins after incubation with MV ( Fig. 2A) . The low level of expression of MV proteins on DCs from non-hSLAM tg mice incubated with MV likely resulted from either nonreceptor-specific binding of MV to mouse DCs or from the intrinsic phagocytic ability of DCs, because nonreplicating, UV-inactivated MV induced an equivalent level of viral glycoprotein expression on similar numbers (5%) of DCs (unpublished data). No significant difference in MV infectivity was observed for other cell types of CD4 + and CD8 + T cells, B cells, and CD11b + cells between tg and nontg mice inoculated with MV. In addition, infectious viruses were produced from in vitro infected DCs of tg mice as detected by cocultivation assay when MV-infected DCs cocultured with B95-8 cells and cytopathic effects and syncytia formation observed on B95-8 cells (unpublished data). When tg and non-tg mice were infected intravenously with MV in vivo, 2 -5% of splenic DCs from tg mice expressed viral proteins, although <1% of DCs from non-tg mice were positive for MV proteins (Fig. 2B ). In vivo, MV infectivity was consistently observed in several independent experiments. However, because 2 -5% of CD11c + DCs were infected in vivo compared to >35% of CD11c + DCs in vitro, we focused our next series of experiments on the in vitro infection model.
Human DCs undergo apoptosis during MV infection (Fugier-Vivier et al., 1997; Servet-Delprat et al., 2000a) . However, because human DCs express both CD46 and also SLAM receptor, it is not known if both or only one of these receptors is responsible. Therefore, MV-infected splenocytes from tg mice were stained for CD11c, Annexin V as an early marker of apoptosis, and 7-AAD to exclude dead cells, and analyzed hereafter by flow cytometry. As shown in Fig. 3A , 29% of splenic CD11c + DCs from tg mice were undergoing apoptosis within 1 day after MV infection, whereas only 9% of mock-infected control cells were Annexin V-positive. By 2 dpi, 52% of MV-incubated splenic DCs scored positive for apoptosis but only 18% of mock-infected cells were positive. BM-derived CD11c + DCs infected with MV also showed enhanced rate of apoptosis (10 -15% above the mock-infected BM-DCs) (unpublished data). Thus, hSLAM expression alone on mouse DCs rendered them permissive to MV infection and resulted in programmed cell death.
We next examined the expression of several important DC surface proteins on splenic CD11c + DCs after MV infection. Costimulatory molecules B7-1, B7-2, and CD40 and MHC class I and II proteins on the surfaces of CD11c + DCs were all downregulated following MV infection (Fig.  3B ). When non-tg DCs were treated with MV, the expression of costimulatory molecules and MHC molecules on their surfaces hardly changed compared to their expression on mock-infected non-tg DCs (unpublished data). Further, MV infection of tg DCs as detected by MV protein expression closely correlated with the reduction in surface expression of these molecules (unpublished data). Because these proteins are known to play a decisive role in DCinduced generation of adaptive T-cell responses, we next evaluated the ability of MV-infected DCs to activate and expand naive T cells.
MV-infected DCs inhibit syngeneic and allogeneic T-cell proliferation
DCs expressing hSLAM were either mock-infected or MV-infected and, at 3 dpi, were UV-irradiated to block trans-infection of T cells. Then, CFSE-labeled syngeneic T lymphocytes from mice engineered to express hSLAM only on those cells through use of an Lck promoter (Hahm et al., 2003) were added to the culture along with PMA and Fig. 4 . Inhibition of mitogen-dependent T-cell proliferation by MV-infected DCs from CD11c-hSLAM tg mice. CD11c + DCs derived from tg BM cells cultured for 10 days with GM-CSF were mock-infected (dotted line) or infected with MV-JW B (solid line). Three dpi, they were UV-irradiated and then mixed with CFSE-labeled lymphocytes in the presence of PMA and ionomycin. The CD4 + and CD8 + T cells were analyzed for proliferation and the expression of CD44, CD25, and CD69 by flow cytometry. Left histograms show the baseline CFSE-labeled cells at day 0 (d0, filled histogram) and proliferation at day 4 (d4, solid line: T cells with MV-infected DCs, or dotted line: T cells with mock-infected DCs).
ionomycin. In response to these mitogens, CD4 + and CD8 + T lymphocytes proliferated normally when incubated with either mock-infected DCs from CD11c-hSLAM tg mice (Fig. 4) or DCs from non-tg mice inoculated with MV ( Fig. 6) . In contrast, MV infected, hSLAM + CD11c + DCs from tg mice greatly inhibited T-cell proliferation (Fig. 4) .
Although T cells exhibited significantly reduced proliferation in response to mitogens in the presence of MV-infected CD11c + DCs, the phenotypic expression of CD44, CD25, and CD69 was not blocked.
Now we addressed the question whether MV-infected hSLAM + CD11c + DCs could generate an MLR. As expected, in coculture of mock-infected hSLAM + CD11c + DCs from FVB/N mice (H-2 q ) and naive T cells from C57BL/6 (H-2 b ), T cells rapidly proliferated at 2 and 4 days. In contrast, MV-infected hSLAM + CD11c + DCs lost their ability to stimulate allogeneic T cells (Fig. 5A) . Analysis of CD8 + T cells showed that they were not or were poorly activated, as judged by their low expression levels of CD44, CD25, and CD69 molecules (Fig. 5B) , and by their inability to proliferate.
No role for hSLAM, IFN-a/b-R, TNF-a, LT-a, and LT-b from T cells in the MV-induced CD11c+ DC-mediated inhibition of T-cell proliferation
Lastly, we evaluated whether hSLAM, IFN-a/h-R, TNF-a, LT-a, and LT-h from T cells played a role in DC-mediated inhibition of T-cell proliferation subsequent to MV infection because these molecules are thought involved in lymphocyte proliferation or survival. First, to test the possibility that MV glycoproteins interacted with hSLAM on T cells thereby sending negative signal to T cells that inhibited T-cell proliferation, we mixed various combinations of either hSLAM + CD11c + DCs or hSLAM À CD11c + DCs with or without MV and added either hSLAM + or hSLAM À T cells. As anticipated, mock-infected or MV-incubated hSLAM À DCs did not inhibit the proliferation of hSLAM (+ or À) T cells because DCs were not infected (Fig. 6) . In contrast, hSLAM + DCs infected with MV significantly impaired proliferation of T lymphocytes either devoid of or bearing hSLAM (Fig. 6) . Therefore, the expression of hSLAM on T cells was not necessary for the inhibition of T-cell proliferation induced by MV-infected DCs, including those from genetically different knock-out (ko) mice that did not express hSLAM on their T cells. The last series of experiments showed that T cells genetically deficient for IFN-a/h-R, TNF-a, LT-a, or LT-h did not proliferate in response to mitogens in the presence of MV-infected CD11c + DCs (Fig. 7) , indicating that none of these T-cell molecules played an individual role in MV-induced CD11c + DC-mediated inhibition of Tcell proliferation.
Discussion
We report here that murine DCs expressing hSLAM were obtained by generating tg mice expressing hSLAM, an MV receptor, and that these DCs were now permissive to wt MV infection. CD11c + DCs isolated from the spleen and BM of these tg mice expressed hSLAM and, when infected with MV, lost the ability to function normally. Such impaired MV-infected DCs did not support T-cell proliferation.
Transgenic mice expressed the hSLAM protein under control of a CD11c promoter, and the presence of this protein on DCs conferred susceptibility to MV infection. Human DCs express SLAM and CD46 and both molecules act as receptors for MV. MV infection was previously shown to induce maturation of human immature DCs derived from blood CD34 + cells and monocytes (Schnorr et al., 1997; Servet-Delprat et al., 2000b) . It is likely that phenotypic maturation of DCs helps immature DCs to transport MV from its primary MV infection area of infection to a secondary site, a lymphoid organ, where T lymphocytes reside. However, MV-infected mouse mature DCs in spleen were highly susceptible to apoptosis and downregulated B7-1, B7-2, CD40, MHC class I, and MHC class II molecules (Fig. 3) , implying that MV-infected mature DCs do not send danger signals to T cells. Rather, MV might exploit the DC network for travel to secondary lymphoid organs by infecting immature DCs that are induced to mature then migrate to these organs. In such organs, subsequently DCs loaded with MV proteins inhibit stimulation of naive T cells. Therefore, MV can likely amplify itself in lymphocytes without being counteracted by newly acquired anti-MV immune responses (Hyypia et al., 1985; Joseph et al., 1975; McChesney et al., 1988; Sullivan et al., 1975) .
Failure to respond to recalled antigenic, mitogenic, and allogeneic stimulation of T cells is a characteristic of MV infection. Similarly, we observed here inhibition of T-cell proliferation using MV-infected mouse CD11c + DCs bearing hSLAM receptor (Figs. 4 and 5) . Without direct viral infection of T cells, mitogen-dependent T-cell proliferation was significantly inhibited by MV-infected DCs, which might have occurred by contact of viral proteins from MV-infected DCs with T cells (Dubois et al., 2001; Klagge et al., 2000; Laine et al., 2003; Marie et al., 2001) or by yet undiscovered soluble factors secreted by the cocultures (Sun et al., 1998) . Interestingly, the expression of T-cell activation markers (CD25, CD69, and CD44) was not impaired by MV-infected DCs when mitogenic stimulus was given for Tcell activation to directly trigger protein kinase C signaling pathway (Fig. 4) . However, when the stimulus was allogeneic, these molecules were poorly expressed on T cells (Fig.  5) , indicating MHC class II-dependent allostimulatory capacity of DCs was severely impaired by MV infection. In both cases, MV-infected DCs strongly inhibited T-cell proliferation regardless of the surface expression level of T-cell activation markers. On studying the defect in proliferation, we found that individual expression of hSLAM, type I IFN receptor, TNF-a, LT-a, or LT-h from T cells was not essential for MV-induced CD11c + DC-mediated inhibition of T-cell proliferation (Figs. 6 and 7) .
Although hSLAM expression on T cells was not required for MV-infected DC-mediated inhibition of T-cell proliferation, MV bound directly to hSLAM; therefore, this protein may alter normal immune system function. SLAM has been identified as the cellular target protein for several viruses (Sidorenko and Clark, 2003) . For example, Morvilliviruses such as rinderpest virus, canine distemper virus, as well as MV use SLAM as their receptor , while Molluscum contagiosum virus encodes proteins that are homologous to SLAM (Bugert et al., 2000) . Moreover, individuals infected with HIV display altered expression of SLAM on their T cells (Meroni et al., 1999) . These observations, in concert, imply that SLAM may play an important role in regulating immune responses to pathogens and is thus chosen by many viruses to subordinate the hosts protective immune arsenal. Because MV downregulates hSLAM on lymphocytes (Hahm et al., 2003; Tanaka et al., 2002) and SLAM associates with SAP and Fyn tyrosine kinase (Chan et al., 2003; Latour et al., 2003) , the effect of MV infection on SLAM-mediated signaling and immune modulation promises to be an area of interest and importance. For this analysis, the tg mice expressing hSLAM receptor separately but specifically on T cells and on DCs should be useful tools. Both human and mouse SLAM possess 100% identity of three tyrosine-based motifs within their cytoplasmic region (Wang et al., 2001) . This mediates SLAM-SAP binding. Therefore, MV binding to human SLAM may likely affect intracellular SLAM-SAP signaling pathway in mouse cells.
In summary, our findings show that MV infection of DCs restricted through the SLAM receptor disrupts DC function by a multifacet strategy. First, the virus infects CD11c + DCs and inhibits their terminal maturation by disordering MHC and costimulatory molecules necessary for antigen presentation. Second, MV infection renders DCs susceptible to apoptosis, which restricts quantitatively the number of DCs capable of generating adaptive immune responses. The events surrounding MV infection are likely to shed knowledge not only on how MV induces immunosuppression but may be mirrored, in part, by a variety of other viruses such as HIV (Knight and Patterson, 1997) , lymphocytic choriomeningitis virus (Sevilla et al., 2003) , cytomegalovirus (Raftery et al., 2001) , herpes simplex virus (Kruse et al., 2000) , dengue virus (Wu et al., 2000) , and other infectious agents who have also developed strategies to avert or usurp the function of DCs for their benefit.
Materials and methods
Construction of expression plasmid
The hSLAM cDNA was PCR-amplified by using pCAG-SLAM, which was provided by Yusuke Yanagi (Kyushu University), as a template in combination with the following primers: 5V-CGGAATTCACCATGGATCCCAAGGGGC-TCCT-3V and 5V -CGGAATTCCCTTCAGAAAGTCCCTT-TGTTGG-3V. To construct pCD11c-hSLAM, amplified hSLAM cDNA was digested with EcoRI and then cloned into an EcoRI-treated pCD11c vector, which was obtained from Dan R. Littman (New York University Medical Center). The pCD11c vector contains CD11c promoter and a hglobin expression cassette that has a transcription terminator for efficient gene expression in tg mice (Brocker et al., 1997) . The entire hSLAM gene and the junction sites between the vector and the inserted gene were sequenced to ensure proper construction.
Generation of tg mice
The 7.7 kb transgene of CD11c promoter-hSLAM fragment was isolated by digestion of pCD11c-hSLAM with XhoI and NotI and was microinjected into either FVB/N or FVB/N Â C57BL/6 fertilized oocytes. The oocytes were then implanted into pseudopregnant CD1 female mice at the TSRI transgenic facility. Tail biopsies were performed on pups, and DNA was isolated for detection of hSLAM cDNA. Five FVB/N and one FVB/N Â C57BL/6 tg mouse founders were identified using a PCR assay as described (Hahm et al., 2003) .
Mice
Were maintained in the closed breeding colony of TSRI. The origin, genotyping, and use of Lck-hSLAM tg mice (Hahm et al., 2003) , IFN-a/h-receptor (R) ko mice (Muller et al., 1994) , tumor necrosis factor (TNF)-a ko mice (Korner et al., 1997) , lymphotoxin (LT)-a ko mice (Fu et al., 1997) , and LT-h ko mice (Koni et al., 1997; Oldstone et al., 2002) has been reported.
Culture of DCs
BM cells were isolated and cultured as described with minor modifications (Lutz et al., 1999) . BM cells obtained by flushing femurs and tibias with a PBS solution were resuspended in 0.83% of ammonium chloride for 3 min to lyse red blood cells. Then 3 -4 million cells were cultured on a 100mm tissue culture plate with RPMI complete medium containing 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 Ag/ml streptomycin, 10 mM HEPES, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 0.05 mM hmercaptoethanol, and 200 U/ml rmGM-CSF (Peprotech). Every 2 -3 days of culture, half of the medium was removed and replaced by fresh rmGM-CSF-supplemented culture medium. After 10 days of culture, nonadherent cells were pooled by gentle pipetting and used as a source of BMderived DCs. From spleens of tg or non-tg littermates, DCs were obtained after digestion with collagenase D (1 mg/ml, type II, Sigma) at 37 jC for 15 min. To disrupt T-cell -DC complexes, 0.01 M of EDTA was added and incubation continued for 5 min. Single cells were then obtained by mechanical disruption as described (Hahm et al., 2003) . When necessary, splenic DCs were enriched (50 -70%) with appropriate columns (Stem cell Technologies Inc.) and cultured in complete medium containing rmGM-CSF.
Analysis of MV infection
Wt MV, JW strain, required several passages on B95-8 cells (fewer than 10 times) to sufficiently enhance viral titers for experimental study. This virus is referred to as MV-JW B (Hahm et al., 2003; Manchester et al., 2000) . B95-8 cells were maintained in RPMI 1640 medium containing 7% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 Ag/ml streptomycin. For MV-binding to DCs in vitro, BM-derived DCs or splenic DCs from CD11c-hSLAM tg or non-tg mice were incubated with either MV-free media as a negative control (mock infection) or MV-JW B at 0.1-0.5 multiplicity of infection (MOI) on ice for 2 h. After washing with PBS, cells were cultured in complete media containing rmGM-CSF. For MV infection in vivo, 8-to 12-week-old tg or nontg mice were injected intravenously with MV-JW B at a dose of 2 Â 10 6 TCID 50 in a volume of 250 Al. Mice were sacrificed 3-4 days after inoculation and splenocytes harvested as above. For a negative control, MV-free cell supernatants were prepared identically to JW virus stock and used for mock in vivo infection analysis.
Flow cytometric analysis
Incubation of cells with various fluorochrome-conjugated antibodies was carried out for 20 min on ice in PBS containing 1% FBS and 0.1% sodium azide. After washing three times, cells were fixed in 1% formaldehyde in PBS. Antibodies used in this study were specific for murine CD4, CD8, B220, CD11b, CD11c, NK1.1, CD44, CD25, CD69, H-2K q MHC class I, I-A/I-E MHC class II, CD40, B7-1, and B7-2 antibodies (BD PharMingen). Staining for hSLAM was performed with an anti-hSLAM antibody (Advanced Immu-noChemical Inc.) conjugated to Cy5 using a monoclonal antibody labeling kit (Amersham Biosciences). For the detection of surface MV proteins, cells were incubated with a human polyclonal serum to MV (Hahm et al., 2003) for 20 min, washed 3 times, and then stained with FITC or PEconjugated donkey anti-human IgG antibody (Jackson Immunoresearch Laboratories). Fluorescent cells were acquired with a FACSCalibur flow cytometer (Becton Dickinson) then analyzed with FlowJo (Treestar) software.
Proliferation assay
To examine the effect of MV-infected DCs on T-cell proliferation, BM-derived CD11c + DCs from tg or non-tg mice of the FVB/N strain (H-2 q ) were either mock-infected or MV-infected and then UV-irradiated at 3 days postinfection (dpi) to block trans-infection of T cells. MVinfected DCs on 24-well plates were UV-irradiated by 30 min of exposure with a 254-nm UV lamp. This treatment inactivated infectious virus as no infected T cells were observed by FACS analysis in the coculture experiment. Lymphocytes obtained from various Lck-hSLAM tg, nontg, or ko mice were labeled with carboxyfluorescein succidimyl ester (CFSE; Molecular Probes, Eugene, OR) as described (Hahm et al., 2003) , mixed with DCs, treated with 20 ng/ml PMA, and 1 Ag/ml ionomycin, and cultured in complete medium containing 50 U/ml of IL-2. For MLR, splenic T cells of C57BL/6 strain (H-2 b ) were used in the coculture with mock-infected DCs or MV-infected DCs from CD11c-hSLAM tg mice. The level of CFSE fluorescence from T cells was traced by flow cytometric analysis.
Apoptotic analysis
Splenocytes obtained from CD11c-hSLAM tg mice were either mock-infected or infected with MV and cultured with complete media containing GM-CSF. At day 1 and 2 postinfection, cells were stained for surface antigen (CD11callophycocyanin conjugated), washed, and subsequently incubated for 15 min with Annexin V-FITC and 7-aminoactinomycin D (7-AAD) according to the manufacturer's recommendations (Pharmingen). After staining, cells were immediately acquired and analyzed.
